14November2018

A Newspaper for the health conscious

AVONIC LIFE SCIENCES

Pinorc Life Science


Dr S Eswara Reddy
1 1 1 1 1 1 1 1 1 1 Rating 5.00 (2 Votes)

DCGI notice to Amazon on sale of cosmetics without license

Rohit Shishodia
The Drugs Controller General (India), Dr S Eswara Reddy, has issued a show cause notice to Amazon asking why action should not be initiated against it for selling, distributing and manufacturing spurious, adulterated cosmetics without valid license. The notice was sent on October 22, 2018.

Richard Stedman, Group CEO at ACG Engineering
1 1 1 1 1 1 1 1 1 1 Rating 5.00 (1 Vote)

ACG Engineering awarded for designing capsule checkweigher

DTMT Network
ACG Engineering of ACG Group has won the Red Dot Design Award-2018, for designing the concept of the automatic 100% capsule checkweigher. ACG Group offers integrated manufacturing solutions for the pharmaceutical industry.

1 1 1 1 1 1 1 1 1 1 Rating 5.00 (1 Vote)

Indian insurance industry to be US$ 280bn by 2020

BS RAWAT
NEW DELHI: The Indian insurance industry is expected to grow to US$ 280 billion by FY 2020 with the center’s Ayushman Bharat and other growth drivers like rising disposable incomes, presence of global players and easing of the regulatory regime, helping penetration of the insurance culture in the country, according to an ASSOCHAM-APAS study.

Dr Ramesh Hariharan, CEO, Strand Life Sciences
1 1 1 1 1 1 1 1 1 1 Rating 5.00 (1 Vote)

Strand Life Sciences Acquires Quest's India Diagnostics Biz

DTMT Network
Strand Life Sciences, a Bangalore-based diagnostics company, has acquired the India medical diagnostics business of Quest Diagnostics.

Dr S Eswara Reddy
1 1 1 1 1 1 1 1 1 1 Rating 5.00 (1 Vote)

Central panel to decide compensation in faulty ASR hip implants

Rohit Shishodia
Central government has formed a central expert panel to determine the quantum of compensation for the affected patients of faulty ASR hip implants.

1 1 1 1 1 1 1 1 1 1 Rating 5.00 (2 Votes)

Faulty hip implants: Panel recommends J&J should reimburse patients

Rohit Shishodia
An eleven member expert panel has recommended to the government for extension of reimbursement program for patients who have undergone ASR (acetabular surface replacement) hip implants and suffered from adverse affects due to the faulty implants.

GLS Pharma

Cubit Pharma